Form 4: GoodRx Holdings Executive Scott Wagner Reports Stock Transactions
SEC Form 4 Filing
Scott Wagner, Interim CEO of GoodRx Holdings, reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units on May 8, 2024.
Summary
- On May 8, 2024, Scott Wagner, Interim CEO of GoodRx Holdings, reported transactions involving Class A Common Stock and Restricted Stock Units.
- Wagner acquired 70,592 shares of Class A Common Stock through the vesting of Restricted Stock Units.
- Simultaneously, Wagner disposed of 25,188 shares of Class A Common Stock at a price of $7.53 per share.
- Following these transactions, Wagner directly owns 45,404 shares of Class A Common Stock and indirectly owns 182,900 shares through the Wagner Family Trust.
- Wagner also holds 494,140 Restricted Stock Units.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports stock transactions by an executive, which is a routine occurrence. There is no indication of positive or negative sentiment towards the company's performance.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, allowing investors to gauge management's sentiment and confidence in the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 05/08/2024 | Date of earliest transaction: Acquisition and disposal of Class A Common Stock and Restricted Stock Units. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.